Home › Funds › PNC Financial Services › VRTX

PNC Financial Services position in VRTX

VERTEX PHARMACEUTICALS INCORPORATED · Health Care

Latest position (Q2 2026)69.36K sh
Reported value held$34.45M
Portfolio Weight0.02%
First reportedQ3 2021
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q3 2021 31.14K $5.65M New
Q4 2021 51.54K $11.32M Add
Q1 2022 71.16K $18.57M Add
Q2 2022 71.36K $20.11M Hold
Q3 2022 72.60K $21.02M Add
Q4 2022 70.28K $20.29M Reduce
Q1 2023 68.21K $21.49M Reduce
Q2 2023 72.69K $25.58M Add
Q3 2023 74.27K $25.82M Add
Q4 2023 76.70K $31.21M Add
Q1 2024 79.95K $33.42M Add
Q2 2024 75.16K $35.23M Reduce
Q3 2024 79.43K $36.94M Add
Q4 2024 78.62K $31.66M Reduce
Q1 2025 78.16K $37.89M Reduce
Q2 2025 76.16K $33.90M Reduce
Q3 2025 69.77K $27.33M Reduce
Q4 2025 69.42K $31.47M Hold
Q1 2026 71.94K $32.12M Add
Q2 2026 69.36K $34.45M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding VRTX

All VRTX fund holders →